Problems with the outcome measures in randomized controlled trials of traditional Chinese medicine in treating chronic heart failure caused by coronary heart disease: a systematic review
Abstract Background Traditional Chinese medicine (TCM) has gained widespread application in treating chronic heart failure (CHF) secondary to coronary heart disease (CHD). However, the sound clinical evidence is still lacking. Corresponding clinical trials vary considerably in the outcome measures a...
Main Authors: | Jiayuan Hu, Ruijin Qiu, Chengyu Li, Min Li, Qianqian Dai, Shiqi Chen, Chen Zhao, Hongcai Shang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-08-01
|
Series: | BMC Complementary Medicine and Therapies |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12906-021-03378-z |
Similar Items
-
Traditional Chinese Medicine for Coronary Heart Disease: Clinical Evidence and Possible Mechanisms
by: Ke-Jian Zhang, et al.
Published: (2019-08-01) -
Stents in coronary heart disease patients: review of the studies available
by: L. A. Bokeriya, et al.
Published: (2009-02-01) -
Chinese herbal medicine for chronic heart failure: a multicenter, randomized, double-blind, placebo-controlled trial
by: Liangtao Luo, et al.
Published: (2014-10-01) -
INCIDENCE OF HEART FAILURE IN DIABETICS WITH CORONARY HEART DISEASE
by: Stojan Radić, et al.
Published: (2003-01-01) -
Cost-consequence analysis of salvianolate injection for the treatment of coronary heart disease
by: Pengxin Dong, et al.
Published: (2018-06-01)